The landscape of community healthcare in the U.S. has been changing rapidly as major drugstore chains like Rite Aid, Walgreens and CVS announced widespread closures leading to widespread "pharmacy deserts," CNBC reported Oct. 11.
The Biologics Price Competition and Innovation Act of (BPCI Act) of 2009 granted responsibility to the FDA for review and approval of a new class of pharmaceuticals referred to as "Biosimilars." (1)
Danco Laboratories is planning to seek FDA approval for the use of abortion pill Mifeprex for the treatment of miscarriages, The Wall Street Journal reported Oct. 8.
GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion.
The FDA authorized the Healgen Rapid Check COVID-19/Flu A&B Antigen Test for over-the-counter use, the first combination test to receive approval outside of an emergency context, ABC News reported Oct. 8.
The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.
The American Society of Health-System Pharmacists is urging federal health officials to declare a national public health emergency over the IV fluid shortage.
A coalition of healthcare organizations led by the American Hospital Association has filed an amicus brief defending Minnesota's law protecting the 340B drug discount program.
CVS Health is set to lay off more than 630 employees as part of a $2 billion cost-cutting initiative aimed at improving financial performance, The Boston Globe reported Oct. 7.
